Literature DB >> 10451392

Multiple presentation of mitochondrial disorders.

A Nissenkorn1, A Zeharia, D Lev, A Fatal-Valevski, V Barash, A Gutman, S Harel, T Lerman-Sagie.   

Abstract

The aim of this study was to assess the heterogeneous clinical presentations of children with mitochondrial disorders evaluated at a metabolic neurogenetic clinic. The charts of 36 children with highly suspected mitochondrial disorders were reviewed. Thirty one children were diagnosed as having a mitochondrial disorder, based on a suggestive clinical presentation and at least one of the accepted laboratory criteria; however, in five children with no laboratory criteria the diagnosis remained probable. All of the patients had nervous system involvement. Twenty seven patients also had dysfunction of other systems: sensory organs in 15 patients, cardiovascular system in five, gastrointestinal system in 20, urinary system in four, haematopoietic system in four, and endocrine system in nine. The clinical presentation was compatible with an established syndrome in only 15 children. Severe lactic acidosis or ragged red muscle fibres were encountered in very few patients. These results suggest that mitochondrial disorders should be evaluated in children presenting with a complex neurological picture or multisystem involvement.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10451392      PMCID: PMC1718054          DOI: 10.1136/adc.81.3.209

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  35 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.

Authors:  I J Holt; A E Harding; R K Petty; J A Morgan-Hughes
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

Review 3.  Oxidative phosphorylation diseases. Disorders of two genomes.

Authors:  J M Shoffner; D C Wallace
Journal:  Adv Hum Genet       Date:  1990

4.  A familial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia.

Authors:  H Costeff; N Gadoth; N Apter; M Prialnic; H Savir
Journal:  Neurology       Date:  1989-04       Impact factor: 9.910

5.  An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region.

Authors:  M Zeviani; S Servidei; C Gellera; E Bertini; S DiMauro; S DiDonato
Journal:  Nature       Date:  1989-05-25       Impact factor: 49.962

6.  Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation.

Authors:  J M Shoffner; M T Lott; A M Lezza; P Seibel; S W Ballinger; D C Wallace
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

Review 7.  Methods for study of normal and abnormal skeletal muscle mitochondria.

Authors:  H S Sherratt; N J Watmough; M A Johnson; D M Turnbull
Journal:  Methods Biochem Anal       Date:  1988

8.  Fatal lactic acidosis in infancy with a defect of complex III of the respiratory chain.

Authors:  M A Birch-Machin; I M Shepherd; N J Watmough; H S Sherratt; K Bartlett; V M Darley-Usmar; D W Milligan; R J Welch; A Aynsley-Green; D M Turnbull
Journal:  Pediatr Res       Date:  1989-05       Impact factor: 3.756

9.  Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.

Authors:  J M Shoffner; M T Lott; A S Voljavec; S A Soueidan; D A Costigan; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts.

Authors:  K F Sheu; C W Hu; M F Utter
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more
  16 in total

1.  A model of Costeff Syndrome reveals metabolic and protective functions of mitochondrial OPA3.

Authors:  Wuhong Pei; Lisa E Kratz; Isa Bernardini; Raman Sood; Tohei Yokogawa; Heidi Dorward; Carla Ciccone; Richard I Kelley; Yair Anikster; Harold A Burgess; Marjan Huizing; Benjamin Feldman
Journal:  Development       Date:  2010-08-01       Impact factor: 6.868

2.  Previously Unreported Biallelic Mutation in DNAJC19: Are Sensorineural Hearing Loss and Basal Ganglia Lesions Additional Features of Dilated Cardiomyopathy and Ataxia (DCMA) Syndrome?

Authors:  Sema Kalkan Ucar; Johannes A Mayr; René G Feichtinger; Ebru Canda; Mahmut Çoker; Saskia B Wortmann
Journal:  JIMD Rep       Date:  2016-12-08

3.  Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder.

Authors:  Afaf El-Ansary; Geir Bjørklund; Salvatore Chirumbolo; Osima M Alnakhli
Journal:  Metab Brain Dis       Date:  2017-05-11       Impact factor: 3.584

4.  Mitochondrial function in schimke-immunoosseous dysplasia.

Authors:  Thomas Lücke; Jochen H H Ehrich; Anibh M Das
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

5.  An overview of a cohort of South African patients with mitochondrial disorders.

Authors:  Izelle Smuts; Roan Louw; Hanli du Toit; Brenda Klopper; Lodewyk J Mienie; Francois H van der Westhuizen
Journal:  J Inherit Metab Dis       Date:  2010-02-05       Impact factor: 4.982

6.  Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease.

Authors:  Doris D M Lin; Thomas O Crawford; Peter B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

7.  Central precocious puberty may be a manifestation of endocrine dysfunction in pediatric patients with mitochondrial disease.

Authors:  Hyun-Wook Chae; Ji-Hoon Na; Ahreum Kwon; Ho-Seong Kim; Young-Mock Lee
Journal:  Eur J Pediatr       Date:  2020-09-10       Impact factor: 3.183

8.  Clinical presentations of mitochondrial cardiomyopathies.

Authors:  D Lev; A Nissenkorn; E Leshinsky-Silver; M Sadeh; A Zeharia; B-Z Garty; L Blieden; V Barash; T Lerman-Sagie
Journal:  Pediatr Cardiol       Date:  2004-06-08       Impact factor: 1.655

9.  A Diagnostic Algorithm for Mitochondrial Disorders in Estonian Children.

Authors:  K Joost; R J Rodenburg; A Piirsoo; L van den Heuvel; R Zordania; H Põder; I Talvik; K Kilk; U Soomets; K Ounap
Journal:  Mol Syndromol       Date:  2012-07-25

10.  Evidence of cardiovascular autonomic impairment in mitochondrial disorders.

Authors:  Rita Di Leo; Olimpia Musumeci; Cesare de Gregorio; Antonio Recupero; Patrizia Grimaldi; Corrado Messina; Sebastiano Coglitore; Giuseppe Vita; Antonio Toscano
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.